Hyundai Heavy, Aramco team up for green biz based on hydrogen, ammonia
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
According to the Korean No. 1 shipbuilding group on Wednesday, its holding company Hyundai Heavy Industries Holdings Co. and Armaco signed a memorandum of understanding for their joint development of hydrogen and ammonia business models.
Under the MOU, Hyundai Oilbank Co., the refiner under Hyundai Heavy Industries, will import liquefied petroleum gas (LPG) from Aramco to turn out blue hydrogen, which is hydrogen energy with reduced carbon emissions through carbon catching and storing technology in the production process. The hydrogen produced in this way is used in desulfurization facilities or sold as fuel for vehicles and power generation. In addition, carbon dioxide generated during the process will be supplied to Aramco, realizing a ‘zero carbon’ process.
Hyundai Oilbank plans to build 300 hydrogen charging stations by 2040 to sell hydrogen. Hyundai Oilbank will also receive blue ammonia from Aramco and use it as fuel for a liquefied natural gas (LNG) boiler, which is scheduled to be established by 2024.
The two entities’ cooperation will move beyond green fuel development. Korea Shipbuilding & Offshore Engineering Co., the holding company of Hyundai Heavy Industries’ shipyards, will develop the world's first ship that can carry both LPG and carbon dioxide at the same time, as well as an ammonia carrier.
[ⓒ Maeil Business Newspaper & mk.co.kr, All rights reserved]
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- Korean Air, Asiana bolster cargo fleet amid protracted pandemic crisis - Pulse by Maeil Business News Korea
- S. Korea’s major biz groups to jointly invest 43 trn won in hydrogen economy by 2030 - Pulse by Maeil Business News Korea
- Korean car sales in growth Jan despite chip woes, choices restricted to big and small - Pulse by Maeil Business News Korea
- Korea’s indigenous coronavirus vaccine enters Phase 2a study - Pulse by Maeil Business News Korea
- Samsung Bioepis commences clinical trial of its 10th biosimilar - Pulse by Maeil Business News Korea
- 강경준, 상간남 피소…사랑꾼 이미지 타격 [MK픽] - 스타투데이
- 아파트 낙찰가율 90% 돌파…빌라는 ‘눈물’ [감평사의 부동산 현장진단]
- “결혼 전제로 열애”…에일리 연인은 ‘솔로지옥’ 최시훈이었다[공식입장] - MK스포츠
- 이찬원, 이태원 참사에 "노래 못해요" 했다가 봉변 당했다 - 스타투데이
- 양희은·양희경 자매, 오늘(4일) 모친상 - 스타투데이